findmyKOL

Netanya Utay, MD

Basic profile

The University of Texas Southwestern Medical Center

ORCIDNPI
RegionDallas, TX · South CentralSpecialtyInfectious DiseaseFocusInfectious Disease
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Netanya Utay is an Infectious Disease physician affiliated with The University of Texas Southwestern Medical Center. OpenAlex indexes 70 publications with 2,000 citations (h-index 22); ClinicalTrials.gov lists 2 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
70publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,000citations

Total citations across indexed works.

22h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

5200 Harry Hines Blvd
Dallas, TX 752357709

Telephone

214-590-8000

Provider last certified this registry record 24 Aug 2021.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    50%
    Gabapentinoids28.6%
    Gabapentin100%
    Part D<11 patients
    Aminoketone21.4%
    Bupropion Xl100%
    Part D<11 patients
  • Cardiovascular

    30.4%
    Statin30.4%
    Atorvastatin Calcium100%
    Part D<11 patients
  • Anti-infectives

    19.6%
    Azole Antifungal19.6%
    Fluconazole100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”